US quartet advise on $41bn Merck buyout
A quartet of US firms has won lead roles on Merck’s $41bn acquisition of pharmaceuticals rival Schering-Plough. Fried Frank Harris Shriver & Jacobson partners David Shine, Philip Richter, William Reindel and Damian Ridealgh led a team advising Merck on the deal. Wachtell Lipton Rosen & Katz partner Andy Brownstein advised Schering-Plough. Merck is a longstanding […]